WSJ: “Founded in Finland in 2013, Oura is popular among health and longevity enthusiasts…Its rings track metrics such as heart rate, temperature and sleep quality and retail for $349 to $499. Subscribers then pay $5.99 a month, or $69.99 a year, for full access to insights on their health. The company said it has five million paying members. The filing revealed a lucrative—and sticky—subscription business. Gross margins on memberships were 89% in the nine months ended June 30, the company said. Subscribers opened the Oura app more than 3.5 times a day on average in the first three quarters of the fiscal year, it said.”
Anil Dash: “Venture capital was only supposed to be a tiny segment of the overall capital market, but it has expanded to become the primary form of funding that new companies consider — it was never the only way, and it didn’t used to be the default one. VC was meant to be a small percentage of overall investment because it represents the high-risk, high-reward part of a portfolio; to be healthy, most of a portfolio — or most of an economy — needs to focus on assets that are more stable and predictable. But a cancer grows from a cell that a body needs in small, healthy amounts, and that turns deadly when it grows without limit until it harms, or even kills, its host.”
NYTimes: “Balance isn’t a single skill but rather several physical, sensory and cognitive systems working together. As the body ages, those systems can weaken. But there are exercises and habits that can help — and it turns out that balance junkies like Mr. Grosowsky have a lot to teach the rest of us about how to age well.”
Activate: “If India reaches 10 GW of energised IT load by 2030, it will have built the factory. The harder measure is how much of that factory’s revenue comes from independent global customers for whom an Indian company sets the price and keeps the renewal.”
